Probabilities of Pituitary-Adrenal Responsiveness After Steroid Therapy
- 1 July 1964
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 61 (1) , 11-26
- https://doi.org/10.7326/0003-4819-61-1-11
Abstract
Small dosages of adrenal steroids may be administered continuously for years without clinical evidence of pituitary-adrenal unresponsive-ness. Thus, the ingestion of 20 mg of hydrocortisone or related steroids for several years by 117 patients with acne, hirsutism, etc. was not attended by any events suggestive of hypopituitarism or hypoadreno-corticism. On 80 occasions these patients passed uneventfully through stressful diagnostic procedures. Unresponsiveness to intravenous mepyrapone which can be demonstrated during prolonged and uninterrupted small dosage steroid therapy is temporary and does not indicate that surgical stress will prove hazardous. Thus, the administration of hydrocortisone and then dexamethasone to 42 healthy adult males for 3 years was attended by unresponsiveness to intravenous mepyrapone during but not 5 weeks after such therapy. Fifteen surgical procedures were performed during temporary interruption of the steroid therapy without untoward event. Huge amounts of steroids can be given for at least 1 month without fear of subsequent pituitary-adrenal hypofunction. Thus, the daily ingestion of 300 mg of hydrocortisone for 30 days by 11 healthy adults did not prevent the usual responses to mepyrapone 5 weeks after completion of therapy. Our limited experiences indicate that large daily dosages may be continued for 1 year or longer before residual hypofunction can be expected in some. If large dosages of steroids are to be given for years, our data suggest that an intermittent schedule, i.e. on 3 to 5 successive days of each week, is generally not associated with pituitary-adrenal hypofunction. In Cushing''s syndrome of 7 and 8 years duration removal of the adrenal adenoma was followed by normal responsiveness to mepyrapone 6 and 15 months following surgery.Keywords
This publication has 21 references indexed in Scilit:
- Tests of Pituitary ACTH Secretory Capacity.Annals of Internal Medicine, 1963
- CLINICAL USE OF A NEW DIAGNOSTIC AGENT, METHOPYRAPONE (SU-4885), IN PITUITARY AND ADRENOCORTICAL DISORDERSAnnals of Internal Medicine, 1961
- ADRENOCORTICAL RESPONSE TO SURGICAL OPERATIONS IN PATIENTS TREATED WITH CORTICOSTEROIDS OR CORTICOTROPIN PRIOR TO SURGERYJournal of Clinical Endocrinology & Metabolism, 1959
- CLINICAL APPLICATION OF A NEW TEST OF PITUITARY RESERVE*Journal of Clinical Endocrinology & Metabolism, 1959
- EFFECTS OF A BACTERIAL POLYSACCHARIDE (PIROMEN®) ON THE PITUITARY-ADRENAL AXIS: CORTISONE BLOCKADE OF PIROMENINDUCED RELEASE OF ACTHEndocrinology, 1958
- THE BEHAVIOUR OF 14C-CORTISOL AND ESTIMATION OF CORTISOL PRODUCTION RATE IN MAN1958
- Hormonal Regulation of Pituitary Adrenocorticotrophin.Experimental Biology and Medicine, 1958
- EFFECTS OF A BACTERIAL POLYSACCHARIDE (PIROMEN®1) ON THE PITUITARY-ADRENAL AXIS: ADRENAL ASCORBIC ACID, CHOLESTEROL AND HISTOLOGIC ALTERATIONSEndocrinology, 1957
- ADRENAL ATROPHY AND IRREVERSIBLE SHOCK ASSOCIATED WITH CORTISONE THERAPYJAMA, 1952
- A QUANTITATIVE COLOR REACTION FOR CORTISONE AND RELATED 17,21-DIHYDROXY-20-KETOSTEROIDSJournal of Biological Chemistry, 1950